ReviewBiochemistry and biophysics reports2026
The influence of rosmarinic acid on male reproductive health: Biological mechanisms and clinical prospects.
Review in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male infertility is a condition affecting up to 15% of couples worldwide. It is frequently driven by oxidative stress and inflammation that impair spermatogenesis and hormone regulation. Rosmarinic acid (RA) as a naturally occurring polyphenolic compound has appeared as a potent antioxidant and anti-inflammatory agent with promising reproductive benefits. According to experimental models, RA reduces testicular damage brought on by oxidative stress, restores antioxidant enzyme activity, maintains testosterone and gonadotropin levels, and preserves sperm motility and morphology. These effects are mechanistically mediated through inhibition of inflammatory cytokines, protection of Leydig cell steroidogenesis, modification of NF-κB and Nrf2 pathways, and radical scavenging. There is still a lack of sufficient human data despite substantial preclinical validation, and concerns about bioavailability and standardized dosage call for more research. This review consolidates current evidence on RA's chemistry, pharmacokinetics, and mechanistic actions in the male reproductive system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.